Skip Navigation

Recommendation Rituxan now available for CLL patients

Updated Feb 19, 2010, filed in Treating, Chronic Lymphocytic Leukemia
Rituxan (rituximab) is a new drug that has been approved by the FDA to treat CLL (chronic lymphocytic leukemia).